Clearbridge Investments, LLC Abbott Laboratories Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clearbridge Investments, LLC holds 77,883 shares of ABT stock, worth $10 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

77,883

Previous 78,019 0.17%

Holding current value

$10 Million

Previous $8.11 Million 9.54%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $13,609 - $16,065	-136 Reduced 0.17%	77,883 $8.88 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $256,156 - $285,934	-2,543 Reduced 3.16%	78,019 $8.11 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $16.5 Million - $18.3 Million	-150,990 Reduced 65.21%	80,562 $9.16 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $13.6 Million - $16.6 Million	150,597 Added 186.03%	231,552 $25.5 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $33,244 - $39,887	348 Added 0.43%	80,955 $7.84 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $37,288 - $41,547	-370 Reduced 0.46%	80,607 $8.79 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $931,793 - $1.1 Million	-9,620 Reduced 10.62%	80,977 $8.2 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $9,506 - $11,152	100 Added 0.11%	90,597 $9.95 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $39,381 - $45,596	-407 Reduced 0.45%	90,497 $8.76 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $8,063 - $9,746	-79 Reduced 0.09%	90,904 $9.88 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $156,093 - $190,345	-1,369 Reduced 1.48%	90,983 $10.8 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $10,397 - $12,731	-90 Reduced 0.1%	92,352 $13 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $2,683 - $2,968	-23 Reduced 0.02%	92,442 $10.9 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $38,084 - $44,830	-360 Reduced 0.39%	92,465 $10.7 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $4 Million - $4.72 Million	36,777 Added 65.62%	92,825 $11.1 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $57,015 - $62,130	-543 Reduced 0.96%	56,048 $6.14 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $62,040 - $75,343	677 Added 1.21%	56,591 $6.16 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $155,513 - $199,038	2,031 Added 3.77%	55,914 $5.11 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $42,277 - $61,821	673 Added 1.26%	53,883 $4.25 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $1.07 Million - $1.19 Million	-13,567 Reduced 20.32%	53,210 $4.63 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $4,746 - $5,146	58 Added 0.09%	66,777 $5.59 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $3,862 - $4,505	53 Added 0.08%	66,719 $0
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $375,136 - $453,539	-5,665 Reduced 7.83%	66,666 $5.33 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $153,017 - $173,346	2,334 Added 3.33%	72,331 $5.23 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $82,032 - $98,962	-1,349 Reduced 1.89%	69,997 $5.14 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $5,469 - $6,036	-95 Reduced 0.13%	71,346 $4.35 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $274,372 - $310,211	-4,876 Reduced 6.39%	71,441 $4.28 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $100,972 - $108,101	1,881 Added 2.53%	76,317 $4.36 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $21,146 - $23,601	-440 Reduced 0.59%	74,436 $3.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	74,876	74,876 $3.64 Million

Others Institutions Holding ABT

# of Institutions

3,217

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Abbott Laboratories Transaction History